Salbutamol Withdrawn Phase 2 Trials for Asthma Bronchial Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03707678A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
NCT01252758Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma